GlassScriptPhysician profile
Patricia A Grade
NPI 1366541930
$5,743.86
in general payments reported to CMS, 2019-2025
35 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,181 · 2020: $515 · 2021: $1,246 · 2022: $1,154 · 2023: $763 · 2024: $633 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,622 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.06 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $992.38 | 2019-2021 | |
| Hologic Sales and Service, LLC | $892.26 | 2019-2025 | Myosure Tissue Removal Device, Aptima, Novasure |
| Abbvie INC. | $796.20 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Gynesonics, INC. | $781.17 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $459.96 | 2019-2022 | |
| Myovant Sciences INC. | $228.15 | 2021-2022 | |
| Organon LLC | $174.57 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $125.74 | 2019-2023 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $111.09 | 2019-2023 | |
| Exeltis, USA INC. | $98.81 | 2019-2025 | Slynd |
| Millicent US INC | $94.06 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Momentis Surgical INC. | $92.91 | 2021 | |
| Astellas Pharma US INC | $92.52 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $92.30 | 2021-2023 | |
| Daiichi Sankyo INC. | $81.24 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $75.44 | 2023-2025 | Accrufer |
| Coopersurgical, INC. | $72.65 | 2019-2020 | |
| Caldera Medical, INC | $58.55 | 2021 | |
| Minerva Surgical, INC | $57.55 | 2019-2023 | |
| Aspira Women'S Health INC | $41.88 | 2023-2024 | Ova1 |
| Allergan, INC. | $35.90 | 2019-2020 | |
| Channel Medsystems, INC. | $33.84 | 2022 | |
| Lupin INC. | $29.17 | 2019-2021 | |
| Avion Pharmaceuticals | $27.38 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $27.30 | 2019 | |
| Mallinckrodt Enterprises LLC | $21.10 | 2019 | |
| Axonics, INC. | $21.07 | 2022 | |
| Agile Therapeutics, INC. | $20.63 | 2021 | |
| Boston Scientific Corporation | $19.00 | 2021 | |
| Pfizer INC. | $17.52 | 2022 | |
| Mylan Pharmaceuticals INC. | $16.42 | 2020 | |
| Mission Pharmacal Company | $14.45 | 2019 | |
| Si-Bone, INC. | $13.83 | 2025 | |
| Monaghan Medical Corporation | $13.71 | 2023 | Aerochamber |
| Duchesnay USA Incorporated | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Grade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.